Germany Cannabis

Largest Cannabis Co. Curaleaf's $1.5B Projected Revenue For 2025: Analyst Raises Rating To Outperform
Cannabis Shops Could Launch This Year In Germany For 'Scientific Purposes,' Here's Why UK's Medical Marijuana Sales Are Soaring
Top Canadian Cannabis Producer Village Farms Strengthens Board Of Directors As It Eyes Legal Weed Opportunities In Europe
Cannabis Shops Could Launch This Year In Germany For 'Scientific Purposes,' Here's Why UK's Medical Marijuana Sales Are Soaring
Top Canadian Cannabis Producer Village Farms Strengthens Board Of Directors As It Eyes Legal Weed Opportunities In Europe
Colorado Cannabis Company: Q1 Revenue Skyrockets 293% YoY To $1.1M Amid German Market Focus, Eyeing European Expansion
IM Cannabis Doubles Down On Germany Following Legalization Policy Change, Reports YoY Drop In Q1 Gross Profit And Revenue

Germany Cannabis Recent News

Cannabis Companies' Gains - U.S. Versus Canada: Averages Can Be Deceiving, Irrational Market Behavior To Blame?
Recent insights from Viridian Capital Advisors shed light on the bewildering trends in cannabis stocks. Year-to-date (YTD) data indicates that U.S. multi-state operators (MSOs) and Canadian licensed producers (LPs) have experienced drastically different fates. At a glance, U.S. MSOs show an average return of 26.4%, towering over Canadian LPs' modest 1.3%.
Curaleaf Boosts International Presence With Another Cannabis Acquisition
Cannabis giant Curaleaf Holdings is closing its previously announced acquisition of Northern Green Canada, a vertically integrated Canadian licensed cannabis producer focused primarily on expanding in the international market through its EU-GMP certification. Terms of the acquisition of NGC include an initial payment at closing of the company's subordinate voting shares valued at approximately $16 million, subject to a typical post-closing adjustment. In addition, an earnout may also be paid in 2025 based upon the 2024 performance of NGC's operations, up to 50% of which will be cash and the rest paid in additional subordinate voting shares.
No Ganja, Just Beer Allowed At Oktoberfest Despite Cannabis Legalization, Officials Argue Youth Protection
Another Cannabis Pioneer Expands In Germany Via Acquisition As Experts Say 'There's No Stepping Back' From Legalization Wave
Flora Growth Corp. has entered into a definitive agreement to acquire all of the issued and outstanding shares of Hamburg, Germany-based TruHC Pharma GmbH. The company's latest move to further cement its global footprint comes on the heels of a new German cannabis law that went into effect on April 1, which partially legalized cannabis. The new law allows adults over 18 in Germany to legally possess up to 25 grams of dried cannabis and cultivate up to three marijuana plants at home.As previously announced, Flora agreed to purchase TruHC Pharma GmbH in an all-stock deal in exchange for 2,770,562 of its common shares, valued at $6.4 million.
'We Want Fewer People To Consume Cannabis,' German Chancellor Scholz Explains Reform To Chinese Students & More Updates
This Canadian Nursery Is Exporting New Cannabis Strains To German Cannabis Producer Demecan
Big League Genetics, a Canadian cannabis nursery and partner of 3WIN Corp, announced on Wednesday that it has completed the export of cannabis genetics to DEMECAN, a licensed German cannabis producer. The move comes on the heels of last week's legalization of recreational cannabis in Germany. As of April adults over 18 in Germany can legally possess up to 25 grams of dried cannabis and cultivate up to three marijuana plants at home. Beginning July 1, adults can also join not-for-profit social clubs where they can buy up to 25 grams of cannabis, with a cap of 50 grams per month. That cap is 30 grams for members under 21 years old. Marijuana legalization in Germany will be one of many hot topics at the upcoming Benzinga Cannabis Capital Conference that returns to Florida on April 16 and 17.
German Lawmakers Eager To See Phase 2 Of Cannabis Legalization, Weed Giant Curaleaf Considers Listing In Frankfurt
Flora Growth's Stock Trading Higher On Pricing $3.2M Public Offering Of Common Shares
Flora Growth Corp. announced on Thursday the pricing of its underwritten public offering of 1.7 million common shares for aggregate gross proceeds of roughly $3.23 million. Clifford Starke, the company's CEO, and an existing investor have agreed to purchase, and have been allocated by Aegis Capital Corp., Common Shares in the offering. Flora said it will use the net proceeds from the transaction that is expected to close on or about Monday, April 8 for general corporate and working capital needs. The move came on the heels of the company's latest move to further cement its global footprint via acquisition in Germany.
The Face Of Germany's Cannabis Legalization: Who's The Mysterious Woman In A Fox Mask Featured On CNN, Telegraph?
In the swirl of media spotlight that followed Germany's groundbreaking move to legalize recreational cannabis, one figure stood out starkly against the backdrop of celebration and debate: Antifuchs, a German rapper known
This Cannabis Pioneer Is Ramping Up Its Presence In Germany As Weed Legalization Takes Effect
Flora Growth Corp. has been positioning itself on the international cannabis stage for years. The Canadian-based producer of cannabinoid organic oils, infused food, and beverage, pharmaceutical grad, medical, and cosmetic-grade derivatives is serving all 50 U.S. states and 28 countries with over 20,000 points of distribution around the world. The company's latest move to further cement its global footprint comes simultaneously with a new German cannabis law that went into effect this Monday, which partially legalized cannabis. Currently, it allows adults over 18 in Germany can legally possess up to 25 grams of dried cannabis and cultivate up to three marijuana plants at home. Flora Growth, which through its wholly-owned subsidiaries has been active in Germany since 2017, revealed last week its plans to launch a cannabis home grow kit, and start up material seeds and cuttings in the European country as it enters the first phase of new recreational cannabis legalization law. This doesn't come as a surprise considering the cannabis recreational market, as per the company's expectations, has the potential to reach $4.2 billion upon legalization with the total European market forecasted to achieve revenues of $10.2 billion.
Weed Legalization In Germany Just Took Effect: Here's What You Need To Know
German legalization will one of the many hot topics at the Benzinga Cannabis Capital Conference in Florida on April 16-17.
IM Cannabis' Q4 Revenue: Gross Profit Drops Due To Negative Impact Of Israel-Hamas War, Sees Germany As Growth Opportunity
IM Cannabis Corp. (NASDAQ: IMCC) (CSE: IMCC) announced on Thursday its financial and operational results for the year ended Dec. 2023. The Toronto-headquartered medical cannabis company with a focus on Israel and Germany reported a 10% year-over-year decrease in revenue to CA$48.8 million ($36 million) in 2023. IM Cannabis attributed it to "negative currency fluctuations and the impact of the Israel-Hamas war on the company's operations." Fourth quarter revenue dropped 26% year-over-year to CA$10.7 million. "As previously warned and as expected, unfortunately, the Israel-Hamas war had a negative impact on our fourth quarter 2023 results, which weighed on our full-year results.," Uri Birenberg, chief financial officer of IMC, said. "Coupled with our fourth quarter of 2023 inventory reduction, the war caused our fourth quarter gross profit to decrease by 68% as compared to the fourth quarter of 2022."
This Canadian Company Emerges Among Cannabis Giants As German Weed Legalization Goes Into Effect
The European cannabis scene is getting more and more interesting with markets like the U.K., Germany, Denmark, Portugal and the Netherlands growing in terms of diversity of products and players. Germany made headlines this past Friday thanks to a historic step towards cannabis legalization. Approvals from both the German Bundesrat and Bundestag made it possible for small possession of marijuana to become legal effective April 1, 2024. A slew of companies that are already established in the European country celebrated the regulatory move. Village Farms International, Inc. was among first to do it, which doesn't come as a surprise as the stage is practically set for Canadian exporters to capture their fair share of the German cannabis market which is projected to expand to €1.7 billion by 2025.
Cannabis Stocks Set To Dominate Germany's New Market: A Surge In Demand Meets Established Expertise
Germany's historic step towards cannabis legalization, effective April 1, 2024, opens a new chapter in the global cannabis industry, presenting substantial opportunities for Canadian leaders Aurora (NASDAQ: ACB), Canopy Growth (NASDAQ: CGC), and Tilra
It's Official: Germany's Partial Cannabis Legalization Takes Effect In April
Nearly a month after the German Bundestag approved partial cannabis legalization on a final floor, the Bundesrat followed suit green-lighting the new law, reported Deutsche Welle.On Friday, the members of Germany's upper house, passed a law without calling in a mediation committee, without calling in a mediation committee, making possession of 25 grams of cannabis for personal consumption storing up to 50 grams at home and keeping three plants for home growth legal in the European country. The new law will become effective on Monday, April 1, making Germany the third country in Europe to legalize adult-use marijuana after Malta and Luxembourg. Moreover, starting July 1, special cannabis clubs which are planned to have up to 500 members will be allowed to cultivate and buy the plant on a limited basis. Additionally, public consumption will also be allowed as long as it is done out of view of children and away from sports facilities, consumption in pedestrian zones between 7 a.m. and 8 p.m. would also be prohibited.
Switzerland Launches Cannabis Study With 7.5k Participants & More Pot Updates In Europe
Curaleaf Strengthens Presence In Germany Via New Cannabis Acquisition
Curaleaf Holdings, Inc. (TSX: CURA) (OTCQX: CURLF) said on Tuesday that it has signed a deal to acquire Northern Green Canada. NGC is a Canadian licensed producer of cannabis, with a focus on expanding in the international market through its EU-GMP certification. The company also partners with Canadian GACP cultivators to produce and distribute finished cannabis products to both the domestic and global markets.
Cannabis Journalist Arrested For Weed Possession In Germany After Barcelona Assignment
The International Cannabis Awards (ICA), often dubbed the "Oscars" of the cannabis world, took place in Barcelona on Wednesday. The prestigious event gathered cannabis experts from all over the world. Shirley Ju, who hosted ICA, couldn't imagine that she would be detained at an airport in Munich, Germany, because of weed.This was definitely a lesson learned to never travel with weed again," the contributing writer for Cannabis Now, cannabis and music journalist and on-camera wrapped up her story she wrote while flying back to Las Angeles.
EXCLUSIVE: From Taboo To Treatment In Germany's Cannabis Landscape (CORRECTED)
Anna-Sofia Kouparanis, co-founder of Bloomwell Group, has overcome challenges in Germany's medical cannabis industry by launching innovative products and empowering female leadership.
Aurora Cannabis Exec Says Company Well-Positioned In Germany, Will Push For Expansion Of Medical Market
Unpacking The $58B Cannabis Market Boom, BDSA Forecasts For 2028
Discover BDSA's $58B cannabis market forecast for 2028, driven by US growth and emerging markets, as detailed by analyst Mitchel-Chesebro.
Germany's Justice Ministers Want To Postpone Cannabis Legalization, Citing Thousands Of Amnesty & Expungement Cases
Experts Agree On Domino Effect Of German Cannabis Legalization, Alert Companies About Rigorous Quality Control Standards & Other Challenges